Self-organized danger and inhibitor signals sustain tissue injury after infection clears
In aged tissue, local extracellular danger signals and a more widely spreading inhibitor could sustain injury after microbial elimination. The claim depends on predicting injury spacing and abolishing persistent injury by redistributing inhibitor at matched mean exposure.
Omega Point 1.2
Stage of verification
- Hypothesis published2026-09-21
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
Lens
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Signalling pathway
Activator–inhibitor signaling
A signaling process combining local self-amplification with inhibition that spreads over a longer range
Where this hypothesis actsAged tissue with persistent localized injury after independently verified pathogen elimination
Hypotheses on this target 1
Inhibition
Activation
Desensitisation
Function preservation
Feedback restoration1
Rhythm restoration
What is proposed
Feedback restoration
Restore stable signaling by extinguishing the spatial instability
With whatNot stated in the record
HowSpatially redistribute inhibitor at matched mean exposure, or neutralize extracellular injury cargo sufficiently to remove the instability
Possible result
Possible abolition of persistent injury, prevention of pattern reformation, and stabilization of SPV_5
From the recordExtinguishing the spatial instability should stabilize SPV_5.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Tissue could keep damaging itself after an infection has gone, even while blood signs of inflammation return to normal. The unexpected move is to locate that persistence in the arrangement of injury-promoting and injury-limiting signals across tissue: their spacing, rather than simply their amount, would keep damaged patches alive. This is a hypothesis generated by the pipeline, not a measured result.
- Histones outside cells are proposed to injure nearby tissue.
- That injury is proposed to release more injury-causing material locally, reinforcing the initial damage.
- Stimulated tissue cells are proposed to produce an inhibitor such as SLPI.
- The inhibitor is proposed to spread farther than the injury-promoting activity, restraining surrounding tissue more broadly.
- The interaction is proposed to make an evenly distributed state recover from uniform disturbances but amplify some uneven disturbances, sustaining separated patches of injury after infection ends.
- Redistributing the inhibitor is predicted to remove this pattern-forming behavior and stabilize the intended functional outcome, which the input labels SPV_5 but does not define.
Imagine small fires that throw sparks only nearby but trigger sprinklers across a wider area. Under the right balance, separate burning patches could remain surrounded by wet ground.
Where the picture breaks: The picture illustrates local reinforcement and wider restraint, but does not show that tissue signals have the required behavior. Wider spread alone cannot establish that a uniform, recovering tissue state would become unstable when signals move through space.
- Master questionstep 01 of 04
Restoring immunity in older people means durably recovering both innate immunity, the body's immediate defenses, and adaptive immunity, its targeted defenses, to healthy young-adult ranges. That restoration must preserve protective immune memory, the ability to respond to previously encountered threats; self-tolerance, restraint against attacking the body's own tissues; and control of latent infections, infections that remain in the body without continuous active disease.
Rests on: The goal itself defines success as durable functional recovery with all three protections preserved, rather than improvement in a single blood measurement.
Stated in the chain - Goal pillarstep 02 of 04
Failures in the sequence from clearing harmful material to ending the injury response, together with damage that amplifies itself, become the chosen focus.
Rests on: The master goal requires recovery without sacrificing protection, but does not identify failure of this sequence as a cause of age-related immune dysfunction.
AssumptionThe relevance of clearance followed by resolution, the ending of an injury response, to the master goal is taken as given. The pillar supplies a topic label rather than an argument for selecting it.
- Gap questionstep 03 of 04
Normal blood signs of inflammation could coexist with worsening tissue function. Suppressing hidden infection and separately neutralizing injury-causing material outside cells are proposed as ways to distinguish ongoing infection from damage that sustains itself, before recovery becomes impossible.
Rests on: The preceding focus on clearance, resolution and damage amplification motivates separating a remaining infectious trigger from continuing tissue injury.
AssumptionThe question assumes a setting in which blood inflammation normalizes while function deteriorates, and treats the two interventions as potentially distinguishing causes. The supplied chain does not establish their selectivity or define the limits beyond which recovery fails.
- Hypothesisstep 04 of 04
Damage-promoting signals outside cells are proposed to reinforce injury nearby, while inhibitory signals spread farther and restrain surrounding tissue. Histones, proteins that normally package cellular genetic material, are candidate injury signals; secretory leucocyte protease inhibitor, or SLPI, a secreted protein that inhibits protein-cutting enzymes, is a candidate restraint. Their interaction could sustain isolated damaged patches after infection has been eliminated.S2S7
Rests on: The gap question supplies the possibility of self-sustaining tissue damage. Pulmonary Circulation (2020, S2) describes histone-related reinforcement of inflammation, but does not establish persistence after infection or a spatial pattern. Communications Biology (2025, S7), in a mouse study of inflammation around teeth, describes secretion and tissue-protective action of SLPI, but does not establish that it spreads farther than injury signals. These support individual ingredients; the supplied hypothesis borrows the spatial mechanism from a mathematical pattern-formation model.
Supported by literature
What is carried, and what is not. Screened sources speak to ingredients in three of the six mechanism links: histone-associated injury, further release of injury-related material, and the presence or protective action of an inhibitor. Cellular Physiology and Biochemistry (2019, S1) reports histone-induced death responses in human red blood cells, Reviews in the Neurosciences (2023, S3; abstract only) describes histone release from activated or damaged cells, and Communications Biology (2025, S7) describes SLPI-related protection in a mouse setting; none establishes the proposed signal ranges, persistent pattern in aged tissue, or sequence from infection clearance to restored function.S1S3S7
Where the reasoning is carried by something unstated · 2
- Goal pillar. The relevance of clearance followed by resolution, the ending of an injury response, to the master goal is taken as given. The pillar supplies a topic label rather than an argument for selecting it.
- Gap question. The question assumes a setting in which blood inflammation normalizes while function deteriorates, and treats the two interventions as potentially distinguishing causes. The supplied chain does not establish their selectivity or define the limits beyond which recovery fails.
How a result here could mislead · 3
- Separated patches of injury could be read as evidence of self-organized pattern formation even if their locations reflect pre-existing differences in tissue structure or cell distribution. What closes it: The proposed matching of tissue scaffold mechanics and cell density must be verified. The model must be fitted before intervention and predict how changing inhibitor spread changes the repeat distance between injury patches. The test also requires evidence that an evenly distributed state recovers from uniform disturbances but amplifies some spatial disturbances; visible patchiness and unequal signal spread are insufficient.
- Improvement after moving SLPI could be credited to the proposed spatial mechanism even if the new placement simply increases inhibition where protein-cutting enzymes are most active. That could overlap with the rival account in which enzymes switch from cutting microbial proteins to cutting host proteins. What closes it: Matched average exposure must be accompanied by measurements of local inhibitor activity and microbial-versus-host protein cutting. Improvement alone is insufficient: the intervention must also satisfy the pre-intervention predictions for changing injury spacing and removing pattern formation.
- Continued deterioration after inhibitor redistribution could be read as rejection of the hypothesis even if redistribution failed to remove the proposed pattern-forming behavior. Conversely, suppressing an injury signal could be mistaken for functional recovery while chromosome damage, damage to the structures carrying genetic material, continues to cause cell loss during tissue repair. What closes it: The experiment must separately establish whether the intervention removed local amplification and wider-range inhibition in the required combination, whether injury patterns stopped reforming, and whether tissue function stabilized. The undefined SPV_5 outcome must be specified before testing, and cell loss during repair must be distinguished from ongoing injury caused by signals outside cells.
What would make this wrong. After independently verified pathogen elimination, failure to find local self-amplification, farther-reaching inhibition, or an evenly distributed state that recovers from uniform disturbances but amplifies some spatial disturbances would reject this specific mechanism. If those properties were present but an intervention demonstrably removed the pattern-forming behavior while persistent injury continued, that would break the claimed causal link between the spatial pattern and continuing injury.
What it would change. If this mechanism held, ending infection and normalizing blood inflammation would not necessarily end a tissue's self-sustaining injury. Work toward durable immune restoration would need to establish whether the spatial arrangement of injury and restraint must also be changed. Even a successful tissue-culture test would not establish restoration of innate and adaptive immunity in older people, preservation of immune memory and self-tolerance, or durable control of latent infections; the supplied input also leaves the proposed functional outcome undefined.
Sources read · 9
Extracellular Histones Induced Eryptotic Death in Human Erythrocytes. · Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2019
“EHs act as a DAMP agent in the human RBCs that induces eryptosis.”
Does not settle: This source does not establish post-clearance tissue injury, extracellular activator–inhibitor spatial patterning, SLPI or other inhibitory signaling, aging effects, localized injury domains, or stabilization of SPV_5.
Extracellular histones in lung dysfunction: a new biomarker and therapeutic target? · Pulmonary circulation · 2020
“NETs are not only the prominent source of circulating histones but can themselves be stimulated by circulating histones and result in the release of myeloperoxidases causing generation of reactive oxygen species and further promoting inflammation.”
Does not settle: This source does not establish injury persistence after microbial clearance, a short-range activator/long-range inhibitor spatial pattern, SLPI involvement, aging effects, localized injury domains, the causal state proposed, SPV_5, or that extinguishing a spatial instability stabilizes it.
Extracellular histones as damage-associated molecular patterns in neuroinflammatory responses. · Reviews in the neurosciences · 2023
“Evidence collected mainly from the peripheral tissues illustrates that histones can be released into the extracellular space by activated or damaged cells.”
Does not settle: This abstract does not establish post-clearance persistence of injury, activator–inhibitor spatial patterning, SLPI or another spreading inhibitor, effects of aging, localized injury domains, matrix versus cell-state causality, SPV_5 stabilization, or whether extinguishing a spatial instability changes injury.
Differential Regulation of Damage-Associated Molecular Pattern Release in a Mouse Model of Skeletal Muscle Ischemia/Reperfusion Injury. · Frontiers in immunology · 2021
“HMGB1, but not histone H3, translocated to the cytoplasm during skeletal muscle ischemia, and was released into the systemic circulation immediately after reperfusion.”
Does not settle: This mouse skeletal-muscle ischemia/reperfusion study does not establish post-infection persistence, spatial activator–inhibitor patterning, SLPI signaling, aging effects, localized injury domains, matrix or cell-state alternatives, SPV_5, or whether extinguishing a spatial instability stabilizes injury.
SLPI deficiency alters airway protease activity and induces cell recruitment in a model of muco-obstructive lung disease. · Frontiers in immunology · 2024
“SLPI is expressed at high levels at mucosal surfaces including in the lung and is secreted by neutrophils, macrophages and epithelial cells lining mucus membranes.”
Does not settle: This mouse study text does not establish post-clearance injury, spatial activator–inhibitor patterning, histone-associated cargo release, localized persistent injury domains in aged tissue, or stabilization of SPV_5.
Secretory leucocyte protease inhibitor regulates bone metabolism and inflammation in experimental mouse periodontitis. · Communications biology · 2025
“Secretory leukocyte protease inhibitors (SLPI), predominantly secreted by epithelial cells, diffuse into the mucosal surface and inhibit excessive tissue loss caused by elastase during inflammation.”
Does not settle: This mouse periodontitis source does not establish post-clearance persistence of injury, a self-organized spatial activator–inhibitor pattern, histone-associated cargo release, age-related localized injury domains, or that the causal state is distributed rather than matrix- or cell-state-based.
SLPI controls neutrophil migration abilities and impacts neutrophil skin infiltration in experimental psoriasis. · Cellular and molecular life sciences : CMLS · 2025
“Since SLPI not only impacts the timeline of neutrophil skin recruitment but also their tissue distribution, the final outcome of SLPI-mediated cutaneous presence of neutrophils might be skin-region dependent.”
Does not settle: This source does not establish post-infection, post-clearance injury; extracellular activator–inhibitor pattern formation; SLPI diffusion range or production by stimulated tissue cells; histone-associated cargo release; aging; persistent localized injury domains; or stabilization of SPV_5.
Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism. · Frontiers in immunology · 2021
“whether EC have trained immunity function which amplifies cytokine responses into cytokine storms”
Does not settle: It does not establish post-clearance tissue injury, activator–inhibitor spatial patterning, extracellular histone-driven local cargo release, SLPI-mediated longer-range inhibition, aging-related localized injury domains, or stabilization of SPV_5.
Gasdermin D in pyroptosis. · Acta pharmaceutica Sinica. B · 2021
“During pyroptosis, GsdmD-N selectively interacts with membrane lipids to form transmembrane pores, through which cellular contents, especially danger signals, are released , .”
Does not settle: This source does not establish post-infection clearance persistence, a spatial activator–inhibitor pattern, histone-specific cargo release, SLPI or another long-range inhibitor, effects of aging, localized injury domains, SPV_5 stabilization, or whether the causal state is distributed signaling rather than altered matrix or permanently switched cells.
The gap this hypothesis explains
What is measured here stands in for what matters, and may not track it.
Can suppressing hidden infection versus neutralizing released damage material distinguish why tissue function worsens before recovery becomes impossible?
Original wording · exactly as the pipeline generated it
When blood inflammation normalizes but function deteriorates, can selective pathogen suppression versus extracellular injury-cargo neutralization distinguish occult infection from autonomous tissue damage before either exceeds recovery limits?
What this question is asking
The question concerns worsening tissue function despite blood measurements suggesting that inflammation has returned to normal. It asks whether selectively suppressing disease-causing organisms, compared with neutralizing potentially harmful material released outside injured cells, can distinguish hidden infection from tissue damage that continues without infection. The comparison would need to show whether functional deterioration responds differently to the two interventions, and whether that difference identifies the responsible cause. The question assumes that existing monitoring detects this mismatch but cannot establish its cause, and asks whether the distinction can be made while recovery remains possible. Its broader setting is restoring immune function in people with age-related immune impairment.
- Inflammation and blood inflammation measurements
- Inflammation is a biological response associated with infection, injury, and repair. Blood measurements track selected features of that response; the supplied input does not identify the measurements or define what counts as normal.
- Tissue function and recovery limits
- Tissue function means how well a body tissue performs its role. Recovery limits name the proposed boundary beyond which that performance cannot be restored; no such boundary is specified or validated here.
- Occult infection and selective pathogen suppression
- Occult infection means infection that has not been readily detected. Selective pathogen suppression means reducing the disease-causing organism with an intervention intended to act specifically on it.
- Extracellular injury cargo and neutralization
- This means material released outside cells during injury, and interventions intended to prevent its harmful activity. It is a broad class of material, not one substance, and released material can also participate in recovery.
- Autonomous tissue damage
- Here this means injury that continues without requiring an ongoing infection. The supplied sources do not establish that independence in the situation posed.
- Age-related immune impairment
- This means reduced or altered performance of the body's defenses associated with aging. The question's broader aim concerns restoring those defenses, but the supplied studies do not establish that outcome.
- RL-2 discordance rules and RL-3 functional tests
- These are pipeline labels for rules that flag mismatched measurements and tests of biological performance. Their expansions, procedures, and validation are not provided.
- Tissue antigen and injury signatures
- An antigen is biological material recognizable by the immune system; an injury signature is a pattern of measurements associated with damage. Finding either does not automatically explain whether the detected material or process is sustaining the damage.
- Connexin-43 channels and Peptide5
- Connexin-43 forms channels in cell membranes. Peptide5 is the channel-blocking intervention associated with protection in the mouse study described by S1.
- Interleukin-1 beta
- An immune signaling protein blocked in S2. That study's reported healing outcome cautions against assuming that blocking an inflammation-related signal necessarily improves repair.
- Extracellular vesicles
- Small membrane-enclosed packages released by cells that carry biological material. They are a class of packages with different contents and effects, including the protective effects described in S3 and injury-associated material examined in S4.
- Prosaposin and receptor
- Prosaposin is the molecule implicated in the protective signaling described in S3. A receptor is a protein that receives a biological signal; the supplied title and quotation spell this study's receptor label differently.
- Nucleic acids and Toll-like receptors 3 and 9
- Nucleic acids are molecules that carry genetic information and can also stimulate immune responses when released from cells. Toll-like receptors 3 and 9 are immune sensors whose activation S4 reports inhibiting through nucleic-acid capture.
- Fluorodeoxyglucose positron emission tomography
- An imaging method using a detectable sugar-like tracer to locate areas of biological activity. S5 discusses its limited ability to distinguish infection from cancer and inflammation without infection.
RL-2 discordance rules and RL-3 functional tests detect abnormalities; tissue antigen and injury signatures do not establish the responsible driver.
The pipeline describes monitoring rules and tests of biological performance that flag a mismatch between reassuring blood results and worsening function. It also assumes that finding recognizable biological material or signs of injury in tissue does not identify what keeps the damage going. If this holds, detecting an abnormality and identifying its cause are separate problems, which motivates the proposed comparison.
S5 supports a narrower concern: the imaging method it discusses sometimes poorly distinguishes infection, cancer, and inflammation without infection. It does not establish the performance of the pipeline's monitoring rules, functional tests, or tissue measurements. The supplied sources do not establish that these rules detect deterioration during a defined period when recovery remains possible.S5
The same question asked without the part nothing read establishes:
- When blood inflammation measurements normalize but tissue function worsens, can suppressing infection versus neutralizing released damage material identify the cause?
- Can responses to infection suppression and released-material neutralization distinguish infection-driven injury from injury that continues independently of infection?
- The responses distinguish the causes Under the question's proposed logic, improvement specifically following infection suppression would support infection as a continuing driver, while improvement specifically following neutralization would support released material as a driver. For this to identify the cause, the responses would need to distinguish those explanations reliably; the supplied sources do not establish that reliability or whether the distinction arrives before recovery is lost.
- The responses do not distinguish the causes If both interventions help, neither helps, or their effects cannot be attributed specifically to their intended targets, the response pattern would leave the cause unresolved. Improvement alone would then be insufficient to classify the deterioration as hidden infection or independently continuing tissue damage.
- The distinction arrives too late Even a reliable distinction could fail the timing requirement if it becomes apparent only after function can no longer recover. Identifying the cause would then settle the explanatory question without establishing the early warning capability the pipeline requires.
If hidden infection sustains injury, suppressing the responsible organism could interrupt the process that damages tissue. If material released by injured cells sustains further damage independently, suppressing infection alone could leave that process active. However, released material can also support recovery: S3 reports that blocking one such signal removes inflammation-resolving effects, although its supplied quotation is unverified. Mistaking a protective signal for harmful material could therefore undermine recovery, while mistaking an intervention response for proof of the underlying cause could leave the actual driver unresolved. The supplied sources do not establish how long either mistake could persist before recovery becomes impossible.
RL-2 discordance rules and RL-3 functional tests detect abnormalities; tissue antigen and injury signatures do not establish the responsible driver.
Discordant recovery triggers investigation within the surveillance window, before persistent dysfunction exceeds clinically justified limits.
Convert reassuring blood-marker discordance into experimentally discriminated causes and validate detection lead time against subsequent functional deterioration.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Post-clearance injury persists because short-range extracellular danger signaling and longer-range inhibitory signaling generate a self-organized spatial pattern. Histone-associated injury induces additional local cargo release, while stimulated tissue cells produce a more widely spreading inhibitor such as SLPI. An aged tissue can consequently maintain sharply localized injury domains surrounded by relatively quiet tissue even after microbial elimination. The causal state resides in a distributed activator–inhibitor field, not in a mechanically altered matrix or a permanently switched cell population. Extinguishing the spatial instability should stabilize SPV_5.
Where the idea comes from
The hypothesis borrows a result from another field. This is what it borrows, and from where.
Developmental morphogenesis and pattern formation: the Gierer–Meinhardt local-activation/lateral-inhibition model. Use ∂a/∂t = D_a∇²a + s_a + ρ_a a²/h − μ_a a and ∂h/∂t = D_h∇²h + s_h + ρ_h a² − μ_h h, with h > 0. Here x is position in tissue; t is elapsed post-control time; a(x,t) is normalized local extracellular injury-inducing activity; h(x,t) is normalized local inhibitory activity; D_a and D_h are their measured effective spatial diffusion coefficients; s_a and s_h are basal production rates; ρ_a is the coefficient for injury-induced local amplification; ρ_h is the coefficient for induced inhibitor production; μ_a and μ_h are first-order removal rates; and ∇² describes spatial concentration curvature. The quadratic terms are candidate effective response laws requiring empirical fitting. A genuine Turing mechanism requires a homogeneous equilibrium stable to uniform perturbations but unstable to some spatial mode: the reaction Jacobian J is stable, while J − q²diag(D_a,D_h) has an eigenvalue with positive real part for some spatial wavenumber q. Differential spread alone is insufficient. The model comes from [Gierer and Meinhardt's original pattern-formation theory](https://doi.org/10.1007/BF00289234); its application here is hypothetical.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
After independently verified pathogen elimination, spatial imaging reveals a reproducible injury wavelength that emerges from small perturbations. A model fitted before intervention must predict how changing inhibitor spread changes that wavelength. Spatial redistribution of inhibitor at matched mean exposure can abolish persistent injury, whereas the same mean exposure delivered in the original pattern does not. Uniform, well-mixed preparations relax toward recovery under matched reaction conditions. Cargo neutralization sufficient to remove the instability prevents pattern reformation; pathogen suppression alone does not. Absence of measurable local self-amplification, longer-range inhibition, or a diffusion-induced unstable mode rejects this specific mechanism rather than being excused as generic feedback.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable wavelength changes, contrasting injury outcomes under matched mean exposure, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Microfluidic tissue cultures permit controlled spatial delivery, live injury reporters, and measurement of effective signal spread. Candidate inhibitor production and range must be measured rather than assumed. Matrix mechanics, cell density, and microbial exposure should remain matched across spatial perturbations.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
After independently verified pathogen elimination, spatial imaging reveals a reproducible injury wavelength that emerges from small perturbations. A model fitted before intervention must predict how changing inhibitor spread changes that wavelength. Spatial redistribution of inhibitor at matched mean exposure can abolish persistent injury, whereas the same mean exposure delivered in the original pattern does not. Uniform, well-mixed preparations relax toward recovery under matched reaction conditions. Cargo neutralization sufficient to remove the instability prevents pattern reformation; pathogen suppression alone does not. Absence of measurable local self-amplification, longer-range inhibition, or a diffusion-induced unstable mode rejects this specific mechanism rather than being excused as generic feedback.
- What would separate them
Clearing residual bacteria redirects protein-cutting enzymes toward host tissue predicts: In paired tissue cultures, pathogen suppression increases host-protein cleavage and new tissue injury after bacterial-substrate turnover, despite falling viable burden and unchanged protease abundance and intrinsic catalytic competence. Protease neutralization prevents this deterioration. Adding purified, readily cleavable microbial substrate during suppression also prevents injury without changing viable burden; a matched cleavage-resistant substrate does not. Isotope-resolved cleavage products must demonstrate reciprocal movement from microbial to host substrates. Failure of substrate replacement to rescue injury despite verified competition rejects this hypothesis. Non-lytic suppression, drug-only controls, and matched released microbial products distinguish substrate diversion from antibiotic toxicity or killing-induced toxin release.
- What would separate them
Infection leaves chromosome damage that causes delayed tissue loss during repair predicts: With verified pathogen suppression and sustained extracellular cargo neutralization, new injury still follows aberrant divisions of cells carrying pre-existing chromosome lesions. Live lineage imaging shows chromosome bridges, segregation errors, or micronucleus formation before cell loss. A reversible experimental delay of cell-cycle entry shifts injury onset by the corresponding interval; releasing the delay restores division-associated injury unless lesions have resolved. Conditioned medium collected before those divisions does not transfer the phenotype to undamaged cells. Pathogen-directed treatment, cargo neutralization, and their combination fail to prevent the initial delayed deaths, distinguishing this mechanism from both extracellular rivals.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.